A target for pre-symptomatic detection, control and prevention of multiple sclerosis in humans
CA 2212606 A1 · Owner: Preddie, Rick E. · Inventors: Bergmann, Johanna E.; Preddie, Rick E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A protein encoded and expressed from within the human myelin basic protein gene (MBP gene) against which immunological based reagents can be prepared for accurate pre-symptomatic diagnosis and therapeutic management of multiple sclerosis in humans is disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 8, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 8, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 8, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.